Dysregulation of PDE4 activity has been implicated in numerous pathological conditions, including neurodegenerative diseases, inflammatory disorders, and certain cancers, making PDE4 a promising therapeutic target [10]. This evidence concerns the gene PDE4A and neurodegenerative disease.